Skip to main content

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In What does "Remember Me" do?

Don't Know Your Password?
Help

Join Now
Sign In

Member Sign In

Username or Email Address

Password

Keep Me Signed In

Don't Know Your Password?

Zacks

more

ObsEva SA (OBSV)

(Delayed Data from NSDQ)

$13.89 USD

-0.12 (-0.86%)

Updated May 3, 2019 04:13 PM ET

After-Market: $13.76 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

NA

View All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

0 items in cart

[OBSV]

Reports for Purchase

Showing records 121 - 140 ( 170 total )

Industry: Medical - Biomedical and Genetics

Record: 121

01/23/2019

Pages: 5

Favorable Safety Observed in PROLONG Trial of OBE022; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 122

01/15/2019

Pages: 6

Lots of Cash and Catalyst Rich 2019 Supports our Positive Outlook

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 123

01/04/2019

Pages: 5

PRIMROSE 2 Completes Enrollment; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 124

12/26/2018

Pages: 6

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 125

12/26/2018

Pages: 25

BEST IDEAS LIST

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 126

12/24/2018

Pages: 7

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 127

12/24/2018

Pages: 28

BEST IDEAS LIST

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 128

12/21/2018

Pages: 10

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 129

12/21/2018

Pages: 10

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 130

12/11/2018

Pages: 9

Rich Pipeline Continues to Advance; Key Catalysts in Next 12-18 Months

Provider: WEDBUSH SECURITIES INC.

Analyst: MOORE B

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 131

12/10/2018

Pages: 9

R-D Day Showcases Best-of-Breed Women''s Health Pipeline; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 132

12/03/2018

Pages: 38

BEST IDEAS LIST -December Update

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 133

12/03/2018

Pages: 11

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 134

12/03/2018

Pages: 6

Adding OBSV to the Best Ideas List

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 135

12/03/2018

Pages: 37

IDEAS LIST

Provider: WEDBUSH SECURITIES INC.

Price: 75.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 136

11/29/2018

Pages: 8

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 137

11/28/2018

Pages: 8

On-Track to Submit Nolasiban MAA in Europe by YE:19

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 138

11/13/2018

Pages: 8

Q3 Financials: Healthy Cash Runway and Catalyst-Heavy Q4:18 and 2019

Provider: WEDBUSH SECURITIES INC.

Analyst: MOUSSATOS L

Price: 25.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 139

10/15/2018

Pages: 5

Additional Live Birth Rate Data Underscores Nolasiban Benefit; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: SELVARAJU R

Price: 10.00

Research Provided by a Third Party

Industry: Medical - Biomedical and Genetics

Record: 140

10/04/2018

Pages: 5

MORNING CALL

Provider: WEDBUSH SECURITIES INC.

Price: 10.00

Research Provided by a Third Party

// eof